WAYS TO REDUCE THE RISK OF TRANSMISSION OF VIRAL-INFECTIONS BY PLASMA AND PLASMA PRODUCTS - A COMPARISON OF METHODS, THEIR ADVANTAGES AND DISADVANTAGES

被引:6
作者
EIBL, J
KAESER, A
HEIMBURGER, N
KARGES, HE
HOROWITZ, B
LUNDBLAD, JL
MOZEN, MM
MANNUCCI, PM
MORFINI, M
MORGENTHALER, JJ
PISZKIEWICZ, D
STEPHAN, W
机构
[1] BEHRINGWERKE AG, RES LABS, D-3550 MARBURG, FED REP GER
[2] NEW YORK BLOOD CTR, NEW YORK, NY 10021 USA
[3] CUTTER BIOL MILES LABS, DIV RES & DEV, BERKELEY, CA 94701 USA
[4] A BIANCHI BONOMI HEMOPHILIA & THROMBOSIS CTR, I-20122 MILAN, ITALY
[5] SWISS RED CROSS, BLOOD TRANSFUS SERV, CENT LAB, CH-3000 BERN 22, SWITZERLAND
[6] TRAVENOL LABS INC, DUARTE, CA 91010 USA
[7] BIOTEST PHARMA GMBH, D-6000 FRANKFURT 73, FED REP GER
关键词
D O I
10.1111/j.1423-0410.1988.tb03910.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:228 / 245
页数:18
相关论文
共 85 条
[1]  
AUERSWALD G, UNPUB SEROLOGICAL CL
[2]  
BARTH R, 1967, Patent No. 1617350
[3]   RECOVERY OF AUSTRALIA ANTIGEN FROM HUMAN PLASMA PRODUCTS SEPARATED BY A MODIFIED COHN FRACTIONATION [J].
BERG, R ;
BERNTSEN, K ;
BJORLING, H ;
ESPMARK, A .
VOX SANGUINIS, 1972, 22 (01) :1-&
[4]   TRANSFUSION-ASSOCIATED HEPATITIS AND AIDS - WHAT IS THE RISK [J].
BOVE, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (04) :242-245
[5]  
BRUNVEZINET F, 1984, LANCET, V1, P1253
[6]   DETECTION OF ANTIBODIES TO HUMAN T-CELL LYMPHOTROPIC VIRUS-III (HTLV-III) WITH AN IMMUNOASSAY EMPLOYING A RECOMBINANT ESCHERICHIA-COLI-DERIVED VIRAL ANTIGENIC PEPTIDE [J].
CHANG, TW ;
KATO, I ;
MCKINNEY, S ;
CHANDA, P ;
BARONE, AD ;
WONGSTAAL, F ;
GALLO, RC ;
CHANG, NT .
BIO-TECHNOLOGY, 1985, 3 (10) :905-909
[7]  
COLOMBO M, 1985, LANCET, V2, P1
[8]  
EDWARDS C, 1985, THROMB HAEMOSTASIS, V54, P206
[9]   TRI(N-BUTYL) PHOSPHATE DETERGENT TREATMENT OF LICENSED THERAPEUTIC AND EXPERIMENTAL BLOOD DERIVATIVES [J].
EDWARDS, CA ;
PIET, MPJ ;
CHIN, S ;
HOROWITZ, B .
VOX SANGUINIS, 1987, 52 (1-2) :53-59
[10]  
EIBL J, 1984, Patent No. 159311